| Formulary Chapter 25: A2 - Borderline substances - Full Chapter
|
| A2.02.02.03 |
Nutritional supplements: >1.5 kcal/mL and ≥5 g protein/100 mL |
|
|
Foodlink Complete Powder
(Nutritional supplement)
|
Formulary
 
|
- Sachets - requires a patient to be able to mix with full-fat milk
- Chocolate, strawberry, banana, natural
- Gluten-free
- Suitable for vegetarians
- May not be appropriate in the following patients
- Patients requiring complete nutrition e.g. reliant entirely on supplements, patients requiring enteral feeding
- Renal patients (CKD stage 4 and 5)
- Vegans and patients with lactose intolerance
Provider notes
Non-formulary
Primary care notes
First-choice product - see Primary Care Guidance
|
 NCL JFC: Oral Nutritional Supplement Formulary in Adults - Primary Care Guidance
|
Altraplen Compact
|
Formulary
|
- Bottle (125mL)
- Banana, hazel-chocolate, strawberry, vanilla
- Clinically lactose and gluten-free
- Suitable for vegetarian, Halal and Kosher diets (except strawberry)
Primary care notes
For patients who did not tolerate first-line choices and lower volume is indicated or fluid restricted- see Primary Care Guidance
|
|
|
AYMES Shake Compact
(Nutritional supplement)
|
Formulary
|
- Sachets - requires a patient to be able to mix with full-fat milk
- Vanilla, banana, strawberry, chocolate, neutral
- Gluten-free
- Halal certified (except strawberry)
- Suitable for vegetarians (except strawberry)
- May not be appropriate in the following patients
- Patients requiring complete nutrition e.g. reliant entirely on supplements, patients requiring enteral feeding
- Renal patients (CKD stage 4 and 5)
- Vegans and patients with lactose intolerance
Provider notes
Non-formulary
Primary care notes
First-choice product for patients who cannot tolerate 200mL presentation - see Primary Care Guidance
|
NCL JFC: Oral Nutritional Supplement Formulary in Adults - Primary Care Guidance
|
Ensure Compact
(Nutritional supplement)
|
Formulary
|
- Bottle (125mL)
- Vanilla, banana, strawberry, café latte
- Contains lactose
- Gluten free
- Halal certified (except strawberry)
- Banana and vanilla flavours Kosher certified
- Suitable for vegetarian diet (except strawberry)
Provider notes
- NMUH:
- RFL:
- RNOH:
- UCLH:
- WH:
Primary care notes
Second-choice product - for patients who did not tolerate first-line choices and lower volume is indicated or fluid restricted - see Primary Care Guidance
|
NCL JFC: Oral Nutritional Supplement Formulary in Adults - Primary Care Guidance
|
Forticreme Complete
(Nutritional supplement)
|
Formulary
|
Provider notes - NMUH:
- Stroke, Dysphagia, fluid restrictions, CAPD, HD, Disease related malnutrition, short bowel syndrome, Intractable malabsorption, pre-operative preparation for those who are malnourished, inflammatory bowel disease, total gastrectomy, bowel fistulae, dysphagiaSemi-solid. High in protein. For dysphagia or requiring a soft diet, tolerating low volume of food
- RFL:
- RNOH:
- UCLH:
- WH:
|
|
|
Fortisip Compact Protein
(Nutritional supplement)
|
Formulary
|
Provider notes
|
|
|
| .... |
| Non Formulary Items |
Complan Shake
(Powder sachet)
|
Non Formulary
|
|
|
|
Foodlink Complete with Fibre
|
Non Formulary
|
|
|
|
Fortisip Compact
|
Non Formulary
|
|
|
|
Fortisip Compact Fibre
|
Non Formulary
|
|
|
|
Fortisip Extra
|
Non Formulary
|
|
|
|
Fresubin 2 kcal Drink
|
Non Formulary
|
|
|
|
Fresubin 2 kcal Fibre Drink
|
Non Formulary
|
|
|
|
Fresubin Creme
|
Non Formulary
|
|
|
|
Fresubin Powder Extra
|
Non Formulary
|
|
|
|
Nutilis Complete Creme Level 3
|
Non Formulary
|
|
|
|
Nutilis Complete Drink Level 3
|
Non Formulary
|
|
|
|
Nutricrem
|
Non Formulary
|
|
|
|
Renilon 7.5
|
Non Formulary
|
|
|
|
Resource 2.0 Fibre
|
Non Formulary
|
|
|
|
Resource Dessert Fruit
|
Non Formulary
|
|
|
|
Vegenat-med Balanced Protein
|
Non Formulary
|
|
|
|
Vegenat-med High Protein
|
Non Formulary
|
|
|
|
| |
Key |
|
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
Traffic Light Status Information
| Status |
Description |
|
Medicines suitable for first-line use within primary care.
Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing. |
|
Medicines suitable for second-line use within primary care.
Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing. |
|
Medicines that should be initiated by a specialist. Prescribing can be transferred to primary care once the patient has been stabilised.
Shared care: For drugs with regular, ongoing need for monitoring and/or assessment of efficacy or toxicity. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the North Central London JFC.
Fact sheet: For drugs with some concerns surrounding safety or efficacy but do not require regular monitoring and/or monitoring of effectiveness/toxicity. |
|
Medicines which should normally be prescribed by specialists only (hospital only).
For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care. |
|
Medicines on hospital formularies which have not been reviewed for suitability in primary care. |
|
Medicines not recommended for routine use in primary or secondary care.
Medicines, which the North Central London JFC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data. |
|
|
|
